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Background:  The mechanism of loss of cardioprotection by IPC during hyperglycemia (HG) remains unclear. Because protein S-nitrosylation by 
nitric oxide (NO) has been implicated in cardioprotection afforded by IPC, we hypothesized that the deficiency of tetrahydrobiopterin (BH4), a co-
factor of NO synthase (NOS), and the resultant decrease in bioavailable NO and protein S-nitrosylation is responsible for the loss of cardioprotective 
effects mediated by IPC during HG.
Methods:  Isolated rat hearts were perfused in normal glucose (NG; 5.5 mM) or high glucose (HG; 20 mM) conditions and underwent IPC with 3 
cycles of 5 min ischemia and 5 min reperfusion before 30 min ischemia followed by 2 hrs reperfusion. A superoxide scavenger tempol (100 μM) or a 
thiol-reducing agent dithiothreitol (DTT; 1 mM) was administered during IPC.
Results:  IPC improved post-ischemic LV function and reduced infarct size in the heart with NG but not in the heart with HG. Hyperosmotic 
perfusion with mannitol (20 mM) did not affect cardioprotection by IPC. The cardioprotective effect of IPC in the heart with NG was associated 
with an increased NO bioavailability as demonstrated by an increase in cardiac tissue nitrate plus nitrite (NOx) and protein S-nitrosylation. BH4 
was decreased in the heart with HG associated with enhanced superoxide generation and decreased NOx generation and protein S-nitrosylation. 
Although exogenous BH4 (10 μM) did not further increase NOx and protein S-nitrosylation nor did it enhance IPC-mediated cardioprotection in the 
heart with NG, it increased NOx and protein S-nitrosylation and inhibited superoxide generation associated with cardioprotection in the heart with 
HG. A NO-dependent guanylyl cyclase inhibitor ODQ (10 μM) had no effect on IPC-mediated cardioprotection. Tempol inhibited superoxide generation 
without an effect on protein S-nitrosylation and did not confer cardioprotection, while DTT blocked protein S-nitrosylation and IPC-mediated 
cardioprotection in the heart with NG and HG.
Conclusion: BH4 restores cardioprotection by IPC in the heart with HG by increasing bioavailable NO and protein S-nitrosylation.
